Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

VE 303

Next Previous
Drug Profile

VE 303

Alternative Names: VE-303

Latest Information Update: 11 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vedanta Biosciences
  • Class Anti-infectives; Anti-inflammatories; Antibacterials; Bacteria
  • Mechanism of Action Bacteria replacements; Microbiome modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Clostridium difficile infections
  • New Molecular Entity No

Highest Development Phases

  • Phase III Clostridium difficile infections
  • Phase II Hepatic encephalopathy

Most Recent Events

  • 30 Apr 2025 PureTech announces intention to submit Biologics License Application to the US FDA for Clostridioides difficile infection
  • 23 Jan 2025 Efficacy data from a phase II CONSORTIUM trial in Clostridium difficile infections released by Vedanta Biosciences
  • 16 Oct 2024 Updated efficacy data from a phase II CONSORTIUM trial in Clostridium difficile infections released by Vedanta Biosciences

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top